These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1116106)

  • 1. A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: a Southwest Oncology Group study.
    Tranum BL; Haut A; Rivkin S; Weber E; Quagliana JM; Shaw M; Tucker WG; Smith FE; Samson M; Gottlieb J
    Cancer; 1975 Apr; 35(4):1148-53. PubMed ID: 1116106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth curve modification of measurable tumors by 75 mg/m2 of CCNU every 3 weeks.
    Israel L; Chahinian P; Accard JL; Choffel C; Combes PF; Danrigal A; Germouty J; Migueres J; Schaerer R; Sotto JJ
    Eur J Cancer (1965); 1973; 9(11-12):789-97. PubMed ID: 4804306
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
    Klaassen DJ; Rapp E
    Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.
    Perloff M; Muggia FM; Ackerman C
    Cancer Chemother Rep; 1974; 58(3):421-4. PubMed ID: 4841718
    [No Abstract]   [Full Text] [Related]  

  • 5. Methyl-CCNU inclinical cancer therapy.
    Wasserman TH; Slavik M; Carter SK
    Cancer Treat Rev; 1974 Dec; 1(4):251-69. PubMed ID: 4377543
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of methyl-CCNU(NSC-95441) in the treatment of lung cancer.
    Richards F; Pajak TF; Cooper MR; Spurr CL
    Cancer Chemother Rep; 1973; 57(4):419-22. PubMed ID: 4357670
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.
    Maurice P; Glidewell O; Jacquillat C; Silver RT; Carey R; Pas AT; Cornell CJ; Burningham RA; Nissen NI; Holland JF
    Cancer; 1978 May; 41(5):1658-63. PubMed ID: 348294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
    Einhorn LH; Livingston RB; Gottlieb JA
    Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination CCNU and bleomycin therapy for squamous cell carcinoma.
    Lindell TD; Moseley HS; Fletcher WS
    Am Surg; 1974 May; 40(5):281-9. PubMed ID: 4132376
    [No Abstract]   [Full Text] [Related]  

  • 10. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
    De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
    Takita H; Brugarolas A; Mittelman A; Vincent R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-1-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumors--a preliminary report.
    Hildebrand J; Brihaye J; Wagenknecht L; Michel J; Kenis Y
    Eur J Cancer (1965); 1973 Sep; 9(9):627-34. PubMed ID: 4803230
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271).
    Cunningham TJ; Nemoto T; Rosner D; Knight E; Taylor S; Rosenbaum C; Horton J; Dao T
    Cancer Chemother Rep; 1974; 58(5 Pt 1):677-81. PubMed ID: 4138966
    [No Abstract]   [Full Text] [Related]  

  • 14. CCNU and bleomycin in the treatment of cancer: a Southwest Oncology Group Study.
    Hoogstraten B; Haas CD; Haut A; Talley RW; Rivkin S; Isaacs BL
    Med Pediatr Oncol; 1975; 1(2):95-106. PubMed ID: 59307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results with CCNU in resistant Hodgkin's and non-Hodgkin's lymphoma.
    Stolinsky DC; Solomon J; Weiner JM; Bateman JR
    Oncology; 1976; 33(5-6):271-3. PubMed ID: 800240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors.
    Livingston RB; Einhorn LH; Bodey GP; Burgess MA; Freireich EJ; Gottlieb JA
    Cancer; 1975 Aug; 36(2):327-32. PubMed ID: 50870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study.
    Hoogstraten B; Gottlieb JA; Caoili E; Tucker WG; Talley RW; Haut A
    Cancer; 1973 Jul; 32(1):38-43. PubMed ID: 4716783
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Brunner KW; Maurice P; Sonntag RW
    Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of brain tumors with 1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    Takeuchi J; Nakao S; Handa H
    Nihon Geka Hokan; 1973 Apr; 42(2):184-9. PubMed ID: 4738478
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitrosoureas: a reappraisal of clinical trials.
    Katz ME; Glick JH
    Cancer Clin Trials; 1979; 2(4):297-316. PubMed ID: 394866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.